IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Thursday, 28 February 2013

The IP Puzzle That Is 3-D Manufacture

›
Perhaps the last place I had planned to encounter a cutting-edge issue regarding IP was in the column by James Saft, "The Coming Dol...
4 comments:
Wednesday, 27 February 2013

The U.S. National Science Foundation I-Corps Program: The Goal is Commercialization

›
The I-Corps Program is a collaboration between the U.S. National Science Foundation [NSF], Kaufmann Foundation and Deshpande Foundation ...

Dogs and Cats Living Together? The New WIPO, WTO and WHO Book.

›
On February 5, 2013, WIPO, the WTO, and the World Health Organization issued a jointly authored book titled, “Promoting Access to Medical Te...
1 comment:
Wednesday, 20 February 2013

Stronger, Better--even FASTR? The Fair Access to Science and Technology Research Act

›
On Valentine’s Day, the Fair Access to Science andTechnology Research Act [FASTR] was introduced in the U.S. Senate and House of Represen...
1 comment:
Friday, 15 February 2013

What Kind of Damages Does an NPE Deserve?

›
With all of the media attention that has been given the $1.05 billion dollar verdict in the Apple suit against Samsung, it is a bit surpr...
1 comment:
Wednesday, 13 February 2013

SMEs, SSOs and Patent Thickets

›
In this guest posting authored by regular IP Finance contributor Keith Mallinson ( WiseHarbor ), Keith considers the allegedly thorny issues...
1 comment:

What is the Value of IP After A Country (Competitor) Steals It? Coordinating the Private Sector with Government to Protect Against the Theft of Trade Secrets

›
A number of reports have issued from US government officials concerning the theft of trade secrets or cyber-espionage by government sponsore...
Thursday, 7 February 2013

Medical Product Developments and the Valley of Death

›
It is called the "valley of death". While the phrase may seem to conjure up the words of the 23rd Psalm written over two millenn...
1 comment:
Tuesday, 5 February 2013

Basic Research – Soon to be a Thing of the Past?

›
One concern since the Bayh-Dole Act was passed in the United States has been the effect of the Act on the direction of research.   Would the...
2 comments:
‹
›
Home
View web version
Powered by Blogger.